2022

1. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain

   Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 327-334